Suchergebnisse - "Vegh, Z"

PubPharm (17)

1

A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus

enthalten in: Brain, behavior, & immunity - health | 2020

von Daems, C. | Sékulic, M. | Vulsteke, V. | +4

2

THE STORY OF 4-AMINO DIPHENYLAMINE

enthalten in: Proceedings of the 6th International Conference on Chemical Technology, ICCT | 2018

von Králik, M. | Balko, J. | Wenchich, �. | +3

3

Editorial : co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator?

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Vegh, Z. | Bessissow, T. | Afif, W. | +1

CommentOn: Aliment Pharmacol Ther. 2017 Mar;45(6):814-823. - PMID 28105709

4

Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort

enthalten in: Journal of Crohn's & colitis | 2015

von Vegh, Z. | Burisch, J. | Pedersen, N. | +84

ErratumIn: J Crohns Colitis. 2015 Oct;9(10):939. - PMID 26417056

5

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia : results of the 2011 ECCO-EpiCom inception cohort

enthalten in: Journal of Crohn's & colitis | 2014

von Vegh, Z. | Burisch, J. | Pedersen, N. | +31

6

Health care and patients' education in a European inflammatory bowel disease inception cohort : an ECCO-EpiCom study

enthalten in: Journal of Crohn's & colitis | 2014

von Burisch, J. | Vegh, Z. | Pedersen, N. | +48

7

Improved spatial learning is associated with increased hippocampal but not prefrontal long-term potentiation in mGluR4 knockout mice

enthalten in: Genes, brain, and behavior | 2013

von Iscru, E. | Goddyn, H. | Ahmed, T. | +3

8

LPA5 receptor plays a role in pain sensitivity, emotional exploration and reversal learning

enthalten in: Genes, brain, and behavior | 2012

von Callaerts-Vegh, Z. | Leo, S. | Vermaercke, B. | +2

9

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2011

von Kiss, L. | Szamosi, T. | Molnar, T. | +22

10

Burden of multidrug-resistant organisms in Hungary

enthalten in: BMC Proceedings | 2011

von Szilágyi, E. | Tóth, �. | Végh, Z.